328 results on '"Redlich Kurt"'
Search Results
2. Bona fide dendritic cells are pivotal precursors for osteoclasts
3. MicroRNA-146a governs fibroblast activation and joint pathology in arthritis
4. Bona fide dendritic cells are pivotal precursors for osteoclasts.
5. Effects of cilengitide in osteoclast maturation and behavior
6. Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice
7. Analysis of combined deficiency of interleukin-1 and -6 versus single deficiencies in TNF-mediated arthritis and systemic bone loss
8. TNF-Induced Structural Joint Damage Is Mediated by IL-1
9. 04.07 Microrna-146a controls local bone destruction by regulating fibroblast induced osteoclastogenesis in inflammatory arthritis
10. 04.15 Resolution of systemic inflammatory processes and regeneration of inflammation-driven bone damage upon tnf blockade as monitored by in vivo multimodal pet-ct imaging in tnf driven experimental arthritis
11. 01.11 Resident non-classical monocytes are critically important for tissue destruction in arthritis
12. Mechanisms of tissue damage in arthritis
13. Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
14. FHL2 regulates the resolution of tissue damage in chronic inflammatory arthritis
15. Economic burden of osteoporotic fractures in Austria
16. Effects of 18β-Glycyrrhetinic acid in hTNFtg mice – a model of rheumatoid arthritis
17. Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells
18. Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis
19. Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomized controlled trial
20. List of Contributors
21. Rheumatoid Arthritis
22. Pro-inflammatory cytokines in rheumatoid arthritis: Pathogenetic and therapeutic aspects
23. Putting patients first: the need for evidence-based and patient-centered standards of care in rheumatoid arthritis
24. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
25. Soluble RANKL and risk of nontraumatic fracture
26. Tumor necrosis factor–inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor–driven model of rheumatoid arthritis
27. Osteoclasts and Osteoblasts
28. Contributors
29. Relationship between inflammation, bone destruction, and osteoproliferation in the HLA–B27/human β2-microglobulin–transgenic rat model of spondylarthritis
30. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis
31. Targeting TNF receptors in rheumatoid arthritis
32. OPINION: The pathogenesis of rheumatoid arthritis: new insights from old clinical data?
33. Sustained PI3-kinase activity in myeloid cells enhances osteoclastogenesis and augments local bone destruction
34. Muscle wasting in hTNFtg mice, an animal model for rheumatoid arthritis, due to increased cathepsin L expression
35. Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results
36. Essential Role of Microrna-155 in the Pathogenesis of Autoimmune Arthritis in Mice
37. Multi-targeted kinase inhibitor PKC412 diminishes osteoclastogenesis and counteracts osteoclast function in vitro
38. Micro-RNA 155 controls the pathogenesis of autoimmune arthritis
39. Nicotinic acetylcholine receptor activation completely blocks osteoclastogenesis by interfering with osteoclast precursor differentiation in vitro
40. Combined depletion of interleukin 1 and interleukin 6 does not exceed single depletion of interleukin 1 in TNF mediated arthritis
41. Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis
42. Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis
43. Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis
44. Running has a negative effect on bone metabolism and proinflammatory status in male aged rats
45. Cytokines as Therapeutic Targets: Advances and Limitations
46. Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis
47. High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study
48. Pre-arthritis: a concept whose time has come
49. Activation of p38 MAPK Is a Key Step in Tumor Necrosis Factor–Mediated Inflammatory Bone Destruction
50. Mechanisms of Disease: the link between RANKL and arthritic bone disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.